InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
32%
T+90 mean return
-5.2%
Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Nash Huw M., Chief Operating Officer. Insider active across 1 company, notably Stoke Therapeutics, Inc.. Cumulatively, 20 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €30k. History available since 1 June 2021. The latest transaction was disclosed on 2 July 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations20 total
2,467 shares@ US$13.10114.7% of flowCommon StockSEC:0001415889-24-019169:0
50,000 shares@ US$0.409.0% of flowCommon StockSEC:0001415889-24-014093:0
50,000 shares@ US$0.409.1% of flowCommon StockSEC:0001415889-24-009993:0
13,100 shares0Common StockSEC:0001415889-24-008686:0
3,800 shares@ US$2.193.6% of flowCommon StockSEC:0001209191-22-001849
3,800 shares@ US$2.190.0004% mcap5.3% of flowCommon StockSEC:0001209191-22-001849:0
5,700 shares@ US$2.190.0006% mcap8.0% of flowCommon StockSEC:0001209191-21-067950:0
5,700 shares@ US$2.195.4% of flowCommon StockSEC:0001209191-21-067950
3,800 shares@ US$2.190.0004% mcap5.2% of flowCommon StockSEC:0001209191-21-062772:0
3,800 shares@ US$2.193.5% of flowCommon StockSEC:0001209191-21-062772
5,700 shares@ US$2.190.0006% mcap7.8% of flowCommon StockSEC:0001209191-21-059111:0
5,700 shares@ US$2.195.3% of flowCommon StockSEC:0001209191-21-059111
5,700 shares@ US$2.190.0006% mcap7.6% of flowCommon StockSEC:0001209191-21-054552:0
5,700 shares@ US$2.195.1% of flowCommon StockSEC:0001209191-21-054552
5,700 shares@ US$2.190.0006% mcap7.6% of flowCommon StockSEC:0001209191-21-049793:0
5,700 shares@ US$2.195.1% of flowCommon StockSEC:0001209191-21-049793
5,700 shares@ US$2.195.1% of flowCommon StockSEC:0001209191-21-045097
5,700 shares@ US$2.190.0006% mcap7.6% of flowCommon StockSEC:0001209191-21-045097:0
575 shares@ US$2.190.0001% mcap0.7% of flowCommon StockSEC:0001209191-21-037839:0
575 shares@ US$2.190.5% of flowCommon StockSEC:0001209191-21-037839
20 of 20 declarations
About Nash Huw M.
Nash Huw M. is an executive at Stoke Therapeutics, Inc.
